NEWS & VIEWS

Global private equity and venture capital news and research

Posts Tagged ‘cancer NuCana’

11 April 2014

Sofinnova Ventures leads $57m Series C round for anti-cancer company NuCana

cancer band pink_sq Sofinnova Ventures has led a $57m Series C financing round for anti-cancer medicine developer NuCana.


Legals & Terms of UsePrivacy Policy


AltAssets is registered as a trademark of Investor Networks Limited (06695690).
Registered Office: Zetland House, 5-25 Scrutton St, London EC2A 4HJ
Content is © AltAssets 2000-2014